NO974101L - Anvendelse av penciclovir for behandling av human herpes virus-8 - Google Patents

Anvendelse av penciclovir for behandling av human herpes virus-8

Info

Publication number: NO974101L
Authority: NO; Norway
Prior art keywords: treatment; penciclovir; herpes virus; human herpes; bioprecursor
Prior art date: 1995-03-07

Application number

NO974101A

Other languages

English (en)

Other versions

NO317733B1 (no

NO974101D0 (no

Inventor

Klaus Max Esser

Richard Anthony Vere Hodge

Original Assignee

Smithkline Beecham Plc

Smithkline Beecham Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-03-07

Filing date

1997-09-05

Publication date

1997-09-05

1997-09-05 Application filed by Smithkline Beecham Plc, Smithkline Beecham Corp filed Critical Smithkline Beecham Plc

1997-09-05 Publication of NO974101L publication Critical patent/NO974101L/no

1997-09-05 Publication of NO974101D0 publication Critical patent/NO974101D0/no

2004-12-13 Publication of NO317733B1 publication Critical patent/NO317733B1/no

Links

238000011282 treatment Methods 0.000 title abstract 2
241001502974 Human gammaherpesvirus 8 Species 0.000 title 1
JNTOCHDNEULJHD-UHFFFAOYSA-N Penciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(CCC(CO)CO)C=N2 JNTOCHDNEULJHD-UHFFFAOYSA-N 0.000 title 1
229960001179 penciclovir Drugs 0.000 title 1
229910019142 PO4 Inorganic materials 0.000 abstract 1
125000002252 acyl group Chemical group 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
206010066435 human herpesvirus 8 infection Diseases 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
239000010452 phosphate Substances 0.000 abstract 1
-1 phosphate ester Chemical class 0.000 abstract 1
238000011321 prophylaxis Methods 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Virology (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Molecular Biology (AREA)
AIDS & HIV (AREA)
Transplantation (AREA)
Biotechnology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Tropical Medicine & Parasitology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

NO19974101A 1995-03-07 1997-09-05 Anvendelse av penciclovir for behandling av human herpes virus-8 NO317733B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9504497.0A GB9504497D0 (en)	1995-03-07	1995-03-07	Pharmaceuticals
PCT/EP1996/000933 WO1996027378A2 (en)	1995-03-07	1996-03-05	Use of penciclovir for the treatment of human herpes-virus-8

Publications (3)

Publication Number	Publication Date
NO974101L true NO974101L (no)	1997-09-05
NO974101D0 NO974101D0 (no)	1997-09-05
NO317733B1 NO317733B1 (no)	2004-12-13

Family

ID=10770731

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO19974101A NO317733B1 (no)	1995-03-07	1997-09-05	Anvendelse av penciclovir for behandling av human herpes virus-8

Country Status (22)

Country	Link
US (1)	US6489330B1 (no)
EP (1)	EP0814813B1 (no)
JP (2)	JPH11501625A (no)
KR (1)	KR19980702833A (no)
CN (1)	CN1138545C (no)
AT (1)	ATE254919T1 (no)
AU (1)	AU701739B2 (no)
BR (1)	BR9607663A (no)
CA (1)	CA2214406C (no)
CY (1)	CY2525B1 (no)
CZ (1)	CZ293470B6 (no)
DE (1)	DE69630876T2 (no)
DK (1)	DK0814813T3 (no)
ES (1)	ES2211949T3 (no)
GB (1)	GB9504497D0 (no)
HU (1)	HU226005B1 (no)
NO (1)	NO317733B1 (no)
NZ (1)	NZ303951A (no)
PT (1)	PT814813E (no)
TR (1)	TR199700921T1 (no)
WO (1)	WO1996027378A2 (no)
ZA (1)	ZA961795B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR20090071598A (ko)	2006-09-18	2009-07-01	랩터 파마슈티컬 인코포레이티드	수용체 결합 단백질(ｒａｐ)-접합체 투여에 의한 간 질환의 치료
WO2009126327A1 (en) *	2008-04-11	2009-10-15	Epiphany Biosciences, Inc.	Treatment and/or prevention of multiple sclerosis
US20120077778A1 (en)	2010-09-29	2012-03-29	Andrea Bourdelais	Ladder-Frame Polyether Conjugates

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0141927B1 (en) *	1983-08-18	1991-10-30	Beecham Group Plc	Antiviral guanine derivatives
DE3582399D1 (de) *	1984-09-20	1991-05-08	Beecham Group Plc	Purin-derivate und ihre pharmazeutische verwendung.
DE3671227D1 (de) *	1985-07-27	1990-06-21	Beecham Group Plc	9-substituierte guaninmonohydrate.
AU635642B2 (en)	1990-05-24	1993-03-25	E.R. Squibb & Sons, Inc.	Fluorinated bis(hydroxymethyl) cyclobutyl purines and pyrimidines
GB9015051D0 (en)	1990-07-07	1990-08-29	Beecham Group Plc	Pharmaceutical treatment

1995
- 1995-03-07 GB GBGB9504497.0A patent/GB9504497D0/en active Pending
1996
- 1996-03-05 DE DE69630876T patent/DE69630876T2/de not_active Expired - Fee Related
- 1996-03-05 NZ NZ303951A patent/NZ303951A/xx not_active IP Right Cessation
- 1996-03-05 BR BR9607663A patent/BR9607663A/pt not_active Application Discontinuation
- 1996-03-05 KR KR1019970706240A patent/KR19980702833A/ko not_active Ceased
- 1996-03-05 HU HU9800272A patent/HU226005B1/hu not_active IP Right Cessation
- 1996-03-05 ZA ZA961795A patent/ZA961795B/xx unknown
- 1996-03-05 PT PT96907360T patent/PT814813E/pt unknown
- 1996-03-05 CA CA2214406A patent/CA2214406C/en not_active Expired - Fee Related
- 1996-03-05 CZ CZ19972831A patent/CZ293470B6/cs not_active IP Right Cessation
- 1996-03-05 EP EP96907360A patent/EP0814813B1/en not_active Expired - Lifetime
- 1996-03-05 WO PCT/EP1996/000933 patent/WO1996027378A2/en not_active Ceased
- 1996-03-05 CN CNB961937939A patent/CN1138545C/zh not_active Expired - Fee Related
- 1996-03-05 AU AU51022/96A patent/AU701739B2/en not_active Ceased
- 1996-03-05 ES ES96907360T patent/ES2211949T3/es not_active Expired - Lifetime
- 1996-03-05 DK DK96907360T patent/DK0814813T3/da active
- 1996-03-05 TR TR97/00921T patent/TR199700921T1/xx unknown
- 1996-03-05 JP JP8526607A patent/JPH11501625A/ja not_active Withdrawn
- 1996-03-05 AT AT96907360T patent/ATE254919T1/de not_active IP Right Cessation
1997
- 1997-09-05 NO NO19974101A patent/NO317733B1/no not_active IP Right Cessation
1999
- 1999-12-29 US US09/473,888 patent/US6489330B1/en not_active Expired - Lifetime
2005
- 2005-05-26 CY CY0500032A patent/CY2525B1/xx unknown
2007
- 2007-08-08 JP JP2007206799A patent/JP2007297412A/ja active Pending

Also Published As

Publication number	Publication date
JP2007297412A (ja)	2007-11-15
CY2525B1 (en)	2006-02-08
CN1183722A (zh)	1998-06-03
GB9504497D0 (en)	1995-04-26
EP0814813A2 (en)	1998-01-07
WO1996027378A3 (en)	1997-01-16
JPH11501625A (ja)	1999-02-09
MX9706759A (es)	1997-11-29
ZA961795B (en)	1996-11-25
US6489330B1 (en)	2002-12-03
ATE254919T1 (de)	2003-12-15
PT814813E (pt)	2004-04-30
CN1138545C (zh)	2004-02-18
NO317733B1 (no)	2004-12-13
ES2211949T3 (es)	2004-07-16
KR19980702833A (ko)	1998-08-05
NO974101D0 (no)	1997-09-05
AU5102296A (en)	1996-09-23
TR199700921T1 (xx)	1998-02-21
CA2214406C (en)	2010-12-21
HUP9800272A2 (hu)	2000-05-28
HK1004373A1 (en)	1998-11-27
CA2214406A1 (en)	1996-09-12
CZ283197A3 (cs)	1998-02-18
BR9607663A (pt)	1998-06-16
HUP9800272A3 (en)	2000-12-28
WO1996027378A2 (en)	1996-09-12
HU226005B1 (en)	2008-02-28
DE69630876T2 (de)	2004-09-02
DK0814813T3 (da)	2004-03-22
EP0814813B1 (en)	2003-11-26
NZ303951A (en)	1999-07-29
DE69630876D1 (de)	2004-01-08
AU701739B2 (en)	1999-02-04
CZ293470B6 (cs)	2004-05-12

Legal Events

Date	Code	Title	Description
2011-10-24	MM1K	Lapsed by not paying the annual fees

Publication	Publication Date	Title
RU95107881A (ru)	1996-11-27	Фармацевтическая композиция для лечения аллергических заболеваний, способ антигистаминного лечения, применение композиции для получения лекарственного препарата
CA2321560A1 (en)	1999-09-16	The use of a protein tyrosine inhibitor such as genistein in the treatment of diabetic retinopathy or ocular inflammation
NO974101D0 (no)	1997-09-05	Anvendelse av penciclovir for behandling av human herpes virus-8
DE69019404D1 (de)	1995-06-22	Derivate von Penciclovir zur Behandlung von Hepatitis-B-Infektionen.
EP0351215A3 (en)	1991-08-14	Ester of 9-(2-hydroxyethoxymethyl) guanine
NO307406B1 (no)	2000-04-03	Anvendelse av 1-aryl-3-(4-piperidyl)-indolderivater ved behandling av kognitive forstyrrelser
HUP9900945A2 (hu)	1999-07-28	Nukleozidanalógok herpes simplex vírus fertőzések kombinációs terápiájában
IL111138A (en)	1997-04-15	Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia
DE69429447D1 (de)	2002-01-24	Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 7 infektionen
CA2207503A1 (en)	1996-06-20	Use of aminopurine antiviral agents for the treatment and prophylaxis of latent herpesvirus infections
DE69429538D1 (de)	2002-01-31	Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 6 infektionen
NO163133C (no)	1990-04-11	Analogifremgangsmaate for fremstilling av terapeutisk aktiv 5r, 6s, 8r-6-(1-hydroxyethyl)-2-(2-carbamoyloxy-ethylthio)-penem-3-carboxylsyre.
AU1494395A (en)	1995-09-28	The use of deoxyspergualin for preparing a pharmaceutical for treating hyperreactive inflammatory diseases
AU2013888A (en)	1989-02-02	Uricosuric composition